NF-κB Inhibitors

NF-κB

NF-κB1/p50

RelA/p65

RelB

c-Rel

NF-κB Inhibitors, Agonists, Activators & Modulators

Product Name	NF-κB	NF-κB1/p50	RelA/p65	RelB	c-Rel	Purity
Phorbol 12-myristate 13-acetate	NF-κB					99.66%
BAY 11-7082	NF-κB					99.98%
JSH-23	NF-κB, IC₅₀: 7.1 μM (in RAW 264.7 cells)					99.92%
Shikonin	NF-κB					99.80%
Sulfasalazine			RelA			99.10%
Pyrrolidinedithiocarbamate ammonium	NF-κB					98.57%
Baicalin	NF-κB					99.17%
Dihydroartemisinin			RelA			99.03%
5-Aminosalicylic Acid			p65			≥98.0%
Parthenolide	NF-κB					99.94%
CBL0137 hydrochloride	NF-κB, IC₅₀: 0.47 μM					99.66%
BAY 11-7085	NF-κB					99.99%
Betulinic acid	NF-κB					≥98.0%
SC75741			p65, IC₅₀: 200 nM			99.51%
QNZ	NF-κB, IC₅₀: 11 nM (in human Jurkat cells transfected with pNFκB-Luc)					99.51%
Andrographolide		p50				99.89%
SN50	NF-κB					99.98%
Nafamostat mesylate	I-kappaBalpha					99.85%
20(S)-Ginsenoside Rg3			p65			99.94%
Ginsenoside Rg1			p65			99.91%
Lidocaine	NF-κB					99.96%
Withaferin A	NFκB					99.92%
(-)-DHMEQ			RelA	RelB		98.72%
Ginsenoside Rb1			p65			98.75%
Caffeic acid phenethyl ester	NF-κB					99.96%
Diprovocim	NF-κB					98.35%
Astragalin			p65			99.85%
NF-κΒ activator 1	NF-κB, EC₅₀: 0.9 μM					99.94%
Indole-3-carbinol	NF-κB					98.87%
Maslinic acid			p65			≥98.0%
Muscone	NF-κB					≥98.0%
Saikosaponin D	NF-κB					98.76%
DCZ0415	NF-κB					99.77%
Berbamine	NF-κB					99.79%
Vanillic acid			p65			99.75%
Tomatidine			p65			≥98.0%
Sinomenine hydrochloride	NF-κB					98.67%
Mangiferin		p50	p65			99.98%
Forsythoside B	NF-κB					99.99%
Neferine			p65			99.92%
18α-Glycyrrhetinic acid	NF-κB					99.52%
Astilbin	NF-κB					99.97%
α-Lipoic Acid	NF-κB					99.86%
MnTBAP chloride	NFκB					≥98.0%
Morusin			p65			99.94%
Ginsenoside Re	NF-κB					98.04%
Lidocaine hydrochloride	NF-κB					99.96%
Fibrinogen (Bovine)		p50	p65		c-Rel
Isovitexin	NF-κB					99.82%
Ginsenoside Rd	NF-κB, IC₅₀: 12.05 μM (in HepG2 cells)					98.02%
TNF-α (31-45), human	NF-κB					99.77%
Rhoifolin	NF-κB					99.09%
Stachydrine			p65			≥98.0%
Berbamine dihydrochloride	NF-κB
EUK-134	NF-κB					98.43%
Nimbolide	NF-κB					99.94%
CHPG sodium salt	NF-κB					99.17%
Sarsasapogenin	NF-κB					98.88%
Homoplantaginin			p65			99.90%
(R)-Sulforaphane	NF-κB					99.37%
Engeletin	NF-κB					99.88%
Ginsenoside Rg5			p65			99.86%
Peiminine			p65			99.94%
Ophiopogonin D	NF-κB					99.54%
Stachydrine hydrochloride			p65			≥98.0%
Tenuigenin	NF-κB					99.24%
Cafestol	NF-κB					99.91%
Peimine	NFκB					99.40%
Licochalcone D			p65			99.81%
Guaiacol	NF-κB					99.29%
Neochlorogenic acid			p65			99.07%
Tectochrysin		p50	p65			99.88%
Sciadopitysin	NF-κB					99.19%
Yangonin			RelA			99.79%
CDDO-dhTFEA	NF-κB					99.71%
Ethyl Caffeate	NF-κB					98.89%
Ginsenoside Rg2	NF-κB					98.11%
Inulicin	NF-κB					99.91%
NF-κΒ activator 2	NF-κB, EC₅₀: 1.58 μM					98.35%
Okanin			p65			98.64%
Cornuside	NF-κB					99.95%
Schisantherin A			p65			99.86%
Laquinimod	NF-κB					99.96%
Ginsenoside Rb3	NF-κB, IC₅₀: 8.2 μM (in 293T cell lines)					99.12%
Sauchinone	I-kappaBalpha		p65			99.89%
Triacetylresveratrol	NF-κB					99.58%
IT-901	NF-κB, IC₅₀: 0.1 μM				c-Rel, IC₅₀: 3 μM	≥99.0%
4-O-Methyl honokiol	NF-κB					99.47%
(R)-(-)-Ibuprofen	NF-κB					99.96%
Hesperidin methylchalcone	NF-κB					≥98.0%
2,5-Dihydroxyacetophenone	NF-κB					99.75%
NF-κB/MAPK-IN-1	NF-κB					98.42%
Isoliquiritin apioside	NF-κB					99.87%
Cynaropicrin	NF-κB					99.71%
Naringin Dihydrochalcone	NF-κB					99.65%
CHPG	NF-κB					≥99.0%
Obtusifolin	NF-κB					99.80%
Myrcene	NF-κB
Reticuline	NF-κB					98.91%
JAK-IN-23	NF-κB, IC₅₀: 150.7 nM					98.90%
Erdosteine	NF-κB					99.62%
Cyclo(his-pro) TFA	NF-κB					99.13%
Chelidonic acid	NF-κB					99.91%
Sanggenon C	NF-κB					98.50%
11-Keto-beta-boswellic acid	NF-κB					99.96%
SM-7368	NF-κB					99.90%
14-Deoxy-11,12-didehydroandrographolide	NF-κB					99.91%
Tomatidine hydrochloride			p65			≥98.0%
Fosfenopril	NF-κB					99.89%
Ergolide	NF-κB					99.75%
Lidocaine (Standard)	NF-κB					99.85%
Ginsenoside Rg6	NF-κB, IC₅₀: 29.34 μM (in HepG2 cell) NF-κB, IC₅₀: 25.12 μM (in SK-Hep1 cell)					99.13%
Armepavine			p65			99.53%
Barlerin	NF-κB					99.82%
Oxaprozin	NF-κB					99.95%
CID-2858522	NF-κB, IC₅₀: 70 nM					98.04%
L6H21	NF-κB					99.46%
Deoxyelephantopin	NF-κB					99.97%
Regaloside A			p65			99.76%
TML-6	NF-κB					99.01%
Ginsenoside Rk3	NF-κB, IC₅₀: 14.24 μM (in HepG2 cells) NF-κB, IC₅₀: 15.32 μM (in SK-Hep1 cell)					98.85%
Dendrophenol	NF-κB					99.63%
Penehyclidine hydrochloride	NF-κB					≥99.0%
Anti-inflammatory agent 35	I-kappaBalpha NF-κB		p65			99.77%
Polygalasaponin F	NF-κB					99.74%
Methylthiouracil	NF-κB					≥98.0%
Flaconitine	NF-κB					98.92%
Aconine	NF-κB					99.78%
Adelmidrol	NF-κB					≥98.0%
AT-533	NF-κB					98.86%
Phellodendrine	NF-κB					99.60%
Rubiadin-1-methyl ether			p65			98.89%
TNF-α (31-45), human TFA	NF-κB
α-Lipoic Acid (Standard)	NF-κB					99.90%
R-HP210	NF-κB					98.21%
Anemarsaponin B			p65
Cyclo(his-pro)	NF-κB
8-Deoxygartanin			p65, IC₅₀: 11.3 μM			99.24%
Enniatin B1	NF-κB
Nafamostat	I-kappaBalpha
Nafamostat hydrochloride	I-kappaBalpha
WAY-204688	NF-κB					99.89%
Laquinimod sodium	NF-κB
Penehyclidine	NF-κB
Ginsenoside Rg1 (Standard)			p65
Ginsenoside Rg2 (Standard)	NF-κB
IMD-biphenylC	NF-κB
Anti-inflammatory agent 20	NF-κB
Ginsenoside Re (Standard)	NF-κB
Cudraflavone B	NF-κB
Coelonin	NF-κB
IMD-catechol	NF-κB
IMD-biphenylB	NF-κB
Icariside F2	NF-κB, IC₅₀: 16.25 μM
NLRP3-IN-32			p65
Oxaprozin potassium	NF-κB
Sanggenon A	NF-κB
Sootepin D	NF-κB
Mesalamine impurity P	NF-κB
DHMEQ racemate	NF-κB
NF-κB-IN-14	NF-κB
Eudebeiolide B	NF-κB
α-Lipoic Acid sodium	NF-κB
20(S)-Ginsenoside Rg3 (Standard)			p65
Xanthine oxidase-IN-6	NF-κB
Mumefural	NF-κB
MR2938	NF-κB
Ginsenoside Rd (Standard)	NF-κB
Lidocaine hydrochloride hydrate	NF-κB
Ginsenoside Rb3 (Standard)	NF-κB
Coronalolic acid	NF-κB
Lucidone	NF-κB	p50	p65
NF-κB-IN-3	NF-κB, IC₅₀: 0.70 μM
Echinulin	NF-κB
Ginsenoside Rb1 (Standard)			p65
NF-κB-IN-13	NF-κB
Triphala	NF-κB

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。沪(浦)应急管危经许[2021]201709(QFYS)	站点地图隐私声明
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.	沪ICP备15051369号-4

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。沪(浦)应急管危经许[2021]201709(QFYS)

站点地图隐私声明

姓名
邮箱 *

Sorry, but the email address you supplied was invalid.

NF-κB Inhibitors

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z